| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 41 | 2019 | 3449 | 2.200 |
Why?
|
| Genetic Linkage | 21 | 2019 | 2342 | 1.890 |
Why?
|
| Nuclear Family | 15 | 2017 | 311 | 1.800 |
Why?
|
| Family | 30 | 2019 | 3208 | 1.300 |
Why?
|
| Models, Statistical | 36 | 2012 | 5110 | 1.190 |
Why?
|
| Likelihood Functions | 19 | 2012 | 994 | 1.110 |
Why?
|
| Genetic Predisposition to Disease | 50 | 2023 | 18068 | 1.040 |
Why?
|
| Genetic Markers | 24 | 2012 | 2604 | 1.010 |
Why?
|
| Linkage Disequilibrium | 23 | 2019 | 2000 | 0.780 |
Why?
|
| Biometry | 12 | 2009 | 570 | 0.720 |
Why?
|
| Chromosome Mapping | 13 | 2010 | 4625 | 0.720 |
Why?
|
| Genetics, Population | 6 | 2013 | 944 | 0.620 |
Why?
|
| Longitudinal Studies | 36 | 2015 | 14794 | 0.620 |
Why?
|
| Polymorphism, Single Nucleotide | 45 | 2017 | 16053 | 0.610 |
Why?
|
| Statistics as Topic | 7 | 2017 | 2360 | 0.600 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 12 | 2023 | 3253 | 0.580 |
Why?
|
| Data Interpretation, Statistical | 23 | 2011 | 2714 | 0.580 |
Why?
|
| Quantitative Trait Loci | 8 | 2008 | 2133 | 0.560 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 12801 | 0.550 |
Why?
|
| Haplotypes | 18 | 2017 | 2725 | 0.550 |
Why?
|
| Phenotype | 33 | 2023 | 16731 | 0.540 |
Why?
|
| Genetic Variation | 12 | 2017 | 6611 | 0.510 |
Why?
|
| Computer Simulation | 25 | 2019 | 6291 | 0.440 |
Why?
|
| Asthma | 18 | 2013 | 6293 | 0.440 |
Why?
|
| Bibliometrics | 1 | 2017 | 355 | 0.430 |
Why?
|
| Pedigree | 11 | 2019 | 4545 | 0.400 |
Why?
|
| Body Mass Index | 14 | 2011 | 13055 | 0.380 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2007 | 540 | 0.370 |
Why?
|
| Serpin E2 | 1 | 2011 | 48 | 0.370 |
Why?
|
| Genetic Techniques | 3 | 2011 | 428 | 0.350 |
Why?
|
| Genetic Testing | 11 | 2011 | 3591 | 0.350 |
Why?
|
| Smoking | 11 | 2017 | 9094 | 0.350 |
Why?
|
| Linear Models | 16 | 2013 | 5891 | 0.350 |
Why?
|
| Meta-Analysis as Topic | 6 | 2015 | 1364 | 0.350 |
Why?
|
| Gene Frequency | 20 | 2019 | 3626 | 0.330 |
Why?
|
| Bipolar Disorder | 9 | 2011 | 5131 | 0.320 |
Why?
|
| Pulmonary Emphysema | 3 | 2023 | 689 | 0.320 |
Why?
|
| Genome, Human | 15 | 2017 | 4456 | 0.320 |
Why?
|
| Environment | 4 | 2010 | 1122 | 0.320 |
Why?
|
| Clinical Trials as Topic | 24 | 2011 | 8055 | 0.310 |
Why?
|
| Genotype | 29 | 2010 | 13048 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2010 | 370 | 0.310 |
Why?
|
| Regression Analysis | 13 | 2007 | 6346 | 0.300 |
Why?
|
| Epistasis, Genetic | 1 | 2010 | 353 | 0.300 |
Why?
|
| Software | 9 | 2019 | 4479 | 0.290 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 129 | 0.280 |
Why?
|
| Algorithms | 25 | 2017 | 14201 | 0.280 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2010 | 606 | 0.270 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 2748 | 0.270 |
Why?
|
| Survival Analysis | 7 | 2004 | 10115 | 0.270 |
Why?
|
| Obesity | 16 | 2012 | 13091 | 0.260 |
Why?
|
| Genes | 1 | 2010 | 1824 | 0.260 |
Why?
|
| Humans | 205 | 2023 | 768970 | 0.260 |
Why?
|
| Family Relations | 1 | 2008 | 318 | 0.260 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1470 | 0.250 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 321 | 0.250 |
Why?
|
| Body Weight | 11 | 2012 | 4628 | 0.250 |
Why?
|
| Mass Media | 1 | 2008 | 303 | 0.250 |
Why?
|
| Case-Control Studies | 26 | 2014 | 22296 | 0.250 |
Why?
|
| Emphysema | 2 | 2023 | 236 | 0.250 |
Why?
|
| Genetic Loci | 4 | 2017 | 2630 | 0.240 |
Why?
|
| Inheritance Patterns | 1 | 2007 | 344 | 0.230 |
Why?
|
| Biostatistics | 3 | 2011 | 165 | 0.230 |
Why?
|
| Alleles | 16 | 2017 | 6901 | 0.230 |
Why?
|
| Epidemiologic Methods | 4 | 2009 | 1328 | 0.230 |
Why?
|
| Logistic Models | 15 | 2004 | 13318 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 453 | 0.220 |
Why?
|
| Research Design | 15 | 2017 | 6214 | 0.210 |
Why?
|
| Disease | 1 | 2008 | 673 | 0.210 |
Why?
|
| Peer Group | 1 | 2008 | 698 | 0.200 |
Why?
|
| Pharmacogenetics | 3 | 2011 | 683 | 0.190 |
Why?
|
| Multivariate Analysis | 11 | 2011 | 12095 | 0.190 |
Why?
|
| Motor Activity | 1 | 2011 | 2713 | 0.180 |
Why?
|
| Bulimia | 4 | 2008 | 405 | 0.180 |
Why?
|
| Physical Examination | 1 | 2007 | 1262 | 0.180 |
Why?
|
| Sample Size | 4 | 2010 | 848 | 0.180 |
Why?
|
| Forced Expiratory Volume | 7 | 2015 | 1831 | 0.170 |
Why?
|
| Treatment Refusal | 2 | 2000 | 433 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 7 | 2008 | 3730 | 0.170 |
Why?
|
| Enzymes | 2 | 2013 | 254 | 0.170 |
Why?
|
| Alzheimer Disease | 8 | 2008 | 8760 | 0.170 |
Why?
|
| Child | 47 | 2021 | 80960 | 0.170 |
Why?
|
| Depressive Disorder | 9 | 2012 | 3723 | 0.160 |
Why?
|
| Patient Dropouts | 7 | 2001 | 411 | 0.160 |
Why?
|
| Parents | 5 | 2019 | 3597 | 0.150 |
Why?
|
| Female | 100 | 2023 | 397515 | 0.150 |
Why?
|
| Analysis of Variance | 8 | 2006 | 6236 | 0.150 |
Why?
|
| Malpractice | 8 | 2004 | 561 | 0.150 |
Why?
|
| Male | 90 | 2023 | 365203 | 0.150 |
Why?
|
| Social Isolation | 1 | 2021 | 366 | 0.150 |
Why?
|
| Mathematical Computing | 2 | 2001 | 142 | 0.140 |
Why?
|
| Bulimia Nervosa | 3 | 2012 | 208 | 0.140 |
Why?
|
| Zidovudine | 4 | 2002 | 625 | 0.140 |
Why?
|
| Polymorphism, Genetic | 8 | 2013 | 4251 | 0.140 |
Why?
|
| Family Health | 6 | 2010 | 1255 | 0.140 |
Why?
|
| Exercise | 6 | 2011 | 5954 | 0.140 |
Why?
|
| Siblings | 4 | 2009 | 828 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2015 | 378 | 0.130 |
Why?
|
| Models, Biological | 5 | 2003 | 9499 | 0.130 |
Why?
|
| Therapeutics | 1 | 1996 | 113 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2008 | 3205 | 0.130 |
Why?
|
| School Health Services | 1 | 1999 | 388 | 0.130 |
Why?
|
| PUVA Therapy | 2 | 1994 | 101 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2017 | 1758 | 0.130 |
Why?
|
| Gene Dosage | 3 | 2009 | 1222 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 15471 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 3713 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2011 | 10400 | 0.120 |
Why?
|
| Bayes Theorem | 4 | 2012 | 2360 | 0.120 |
Why?
|
| Child Health Services | 2 | 1999 | 645 | 0.120 |
Why?
|
| Vital Capacity | 2 | 2013 | 996 | 0.120 |
Why?
|
| Models, Theoretical | 7 | 2012 | 3580 | 0.120 |
Why?
|
| Patient Compliance | 2 | 2002 | 2701 | 0.120 |
Why?
|
| Monte Carlo Method | 6 | 2008 | 1262 | 0.120 |
Why?
|
| Environmental Exposure | 2 | 2013 | 4544 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 1038 | 0.110 |
Why?
|
| Cadherins | 2 | 2017 | 906 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 4413 | 0.110 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 168 | 0.110 |
Why?
|
| New England | 1 | 2017 | 1058 | 0.110 |
Why?
|
| Austria | 3 | 2010 | 209 | 0.110 |
Why?
|
| Interleukin-10 | 3 | 2009 | 1183 | 0.110 |
Why?
|
| Canada | 8 | 2008 | 2130 | 0.110 |
Why?
|
| Health Behavior | 2 | 2008 | 2649 | 0.100 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2005 | 360 | 0.100 |
Why?
|
| Iatrogenic Disease | 7 | 1995 | 552 | 0.100 |
Why?
|
| Renal Dialysis | 9 | 1983 | 1789 | 0.100 |
Why?
|
| Mexico | 4 | 2013 | 769 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2004 | 12562 | 0.100 |
Why?
|
| Age of Onset | 6 | 2017 | 3346 | 0.090 |
Why?
|
| Mood Disorders | 3 | 2003 | 1129 | 0.090 |
Why?
|
| alpha-Macroglobulins | 2 | 2003 | 60 | 0.090 |
Why?
|
| Probability | 8 | 2012 | 2483 | 0.090 |
Why?
|
| Risk | 9 | 2012 | 9621 | 0.090 |
Why?
|
| Nasal Decongestants | 1 | 2010 | 29 | 0.090 |
Why?
|
| Schools | 1 | 1999 | 1498 | 0.090 |
Why?
|
| Risk Factors | 30 | 2017 | 74976 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2002 | 2203 | 0.080 |
Why?
|
| Molecular Epidemiology | 1 | 2012 | 473 | 0.080 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 31 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 387 | 0.080 |
Why?
|
| Poverty | 2 | 2021 | 2720 | 0.080 |
Why?
|
| Depressive Disorder, Major | 5 | 2009 | 4818 | 0.080 |
Why?
|
| Middle Aged | 52 | 2017 | 223737 | 0.080 |
Why?
|
| Tobacco Use Disorder | 2 | 2006 | 708 | 0.080 |
Why?
|
| Phenylephrine | 1 | 2010 | 293 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2893 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 658 | 0.080 |
Why?
|
| Apolipoproteins E | 3 | 2017 | 1461 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2009 | 94 | 0.080 |
Why?
|
| Least-Squares Analysis | 3 | 2001 | 367 | 0.080 |
Why?
|
| Ozone | 1 | 2013 | 496 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 609 | 0.080 |
Why?
|
| Pharmacokinetics | 1 | 2008 | 86 | 0.080 |
Why?
|
| Sex Factors | 9 | 2008 | 10633 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2009 | 209 | 0.080 |
Why?
|
| Adolescent Behavior | 2 | 2008 | 1188 | 0.080 |
Why?
|
| Principal Component Analysis | 2 | 2008 | 948 | 0.080 |
Why?
|
| Odds Ratio | 9 | 2008 | 9684 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2003 | 828 | 0.080 |
Why?
|
| Self Disclosure | 2 | 2007 | 248 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4785 | 0.070 |
Why?
|
| X Chromosome | 2 | 2023 | 819 | 0.070 |
Why?
|
| Plasmodium vivax | 1 | 2009 | 203 | 0.070 |
Why?
|
| Patient Care Team | 1 | 1999 | 2528 | 0.070 |
Why?
|
| Malaria, Vivax | 1 | 2009 | 168 | 0.070 |
Why?
|
| Prevalence | 11 | 2010 | 15879 | 0.070 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.070 |
Why?
|
| Confidence Intervals | 3 | 2008 | 2932 | 0.070 |
Why?
|
| Health Promotion | 1 | 1999 | 2210 | 0.070 |
Why?
|
| Life Style | 1 | 1999 | 3931 | 0.070 |
Why?
|
| Metagenomics | 1 | 2011 | 474 | 0.070 |
Why?
|
| Random Allocation | 13 | 1998 | 2394 | 0.070 |
Why?
|
| Receptors, Nicotinic | 2 | 2015 | 494 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1990 | 312 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3810 | 0.070 |
Why?
|
| Lung | 6 | 2017 | 10099 | 0.070 |
Why?
|
| Alcoholism | 3 | 2008 | 1981 | 0.070 |
Why?
|
| Psoriasis | 2 | 1994 | 926 | 0.070 |
Why?
|
| Television | 2 | 1999 | 410 | 0.070 |
Why?
|
| Adult | 50 | 2016 | 223851 | 0.070 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2008 | 217 | 0.070 |
Why?
|
| Medication Errors | 3 | 1998 | 785 | 0.070 |
Why?
|
| Weight Gain | 3 | 2009 | 2359 | 0.070 |
Why?
|
| Cluster Analysis | 4 | 2017 | 2732 | 0.060 |
Why?
|
| Receptors, Lipoprotein | 1 | 2006 | 88 | 0.060 |
Why?
|
| Age Factors | 12 | 2013 | 18435 | 0.060 |
Why?
|
| Sampling Studies | 5 | 2002 | 615 | 0.060 |
Why?
|
| Body Composition | 3 | 2006 | 2462 | 0.060 |
Why?
|
| Fibromyalgia | 2 | 2008 | 407 | 0.060 |
Why?
|
| Adolescent | 28 | 2012 | 89244 | 0.060 |
Why?
|
| Mental Disorders | 5 | 2008 | 6876 | 0.060 |
Why?
|
| Cohort Studies | 11 | 2017 | 41808 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2003 | 432 | 0.060 |
Why?
|
| Dysthymic Disorder | 2 | 2002 | 73 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 878 | 0.060 |
Why?
|
| Risk-Taking | 2 | 2008 | 1023 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1673 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 1985 | 171 | 0.060 |
Why?
|
| Medication Systems, Hospital | 2 | 1995 | 154 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2006 | 334 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 247 | 0.060 |
Why?
|
| Indinavir | 1 | 2003 | 73 | 0.050 |
Why?
|
| Carrier Proteins | 3 | 2015 | 4939 | 0.050 |
Why?
|
| Adipose Tissue | 3 | 2006 | 3335 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1987 | 542 | 0.050 |
Why?
|
| Prisoners | 1 | 2007 | 316 | 0.050 |
Why?
|
| Uremia | 9 | 1983 | 202 | 0.050 |
Why?
|
| Comorbidity | 7 | 2008 | 10592 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 588 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2004 | 243 | 0.050 |
Why?
|
| Reproducibility of Results | 7 | 2010 | 20245 | 0.050 |
Why?
|
| Hematopoietic System | 1 | 1983 | 110 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 605 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2009 | 7885 | 0.050 |
Why?
|
| Anxiety Disorders | 3 | 2003 | 2749 | 0.050 |
Why?
|
| Anorexia Nervosa | 3 | 2012 | 1364 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 216 | 0.050 |
Why?
|
| Bone Density | 2 | 2006 | 3574 | 0.050 |
Why?
|
| Estrogens | 1 | 2009 | 1536 | 0.050 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 454 | 0.050 |
Why?
|
| Computational Biology | 1 | 2014 | 3562 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2005 | 583 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2006 | 592 | 0.050 |
Why?
|
| Panic Disorder | 1 | 2005 | 613 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 737 | 0.050 |
Why?
|
| Blood Urea Nitrogen | 6 | 1983 | 189 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1418 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2014 | 286 | 0.050 |
Why?
|
| Respiratory Sounds | 2 | 1997 | 702 | 0.050 |
Why?
|
| Erythrocyte Indices | 1 | 2002 | 143 | 0.050 |
Why?
|
| Boston | 8 | 2017 | 9377 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 859 | 0.050 |
Why?
|
| HIV Protease Inhibitors | 1 | 2003 | 432 | 0.050 |
Why?
|
| New York | 8 | 2004 | 884 | 0.040 |
Why?
|
| Fetal Development | 1 | 2006 | 777 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2002 | 391 | 0.040 |
Why?
|
| Aged | 28 | 2017 | 171786 | 0.040 |
Why?
|
| Ohio | 1 | 2021 | 321 | 0.040 |
Why?
|
| Health Surveys | 5 | 2004 | 4055 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1994 | 4064 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 239 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2014 | 4432 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2009 | 6030 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2013 | 3443 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2000 | 213 | 0.040 |
Why?
|
| United States | 8 | 2012 | 73186 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2002 | 3438 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2002 | 400 | 0.040 |
Why?
|
| Exons | 2 | 2007 | 2395 | 0.040 |
Why?
|
| Baltimore | 1 | 1999 | 233 | 0.040 |
Why?
|
| Thailand | 2 | 2009 | 288 | 0.040 |
Why?
|
| Menarche | 1 | 2001 | 538 | 0.040 |
Why?
|
| Body Height | 4 | 1995 | 1569 | 0.040 |
Why?
|
| Mutation | 7 | 2021 | 30266 | 0.040 |
Why?
|
| Inpatients | 3 | 1999 | 2569 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 1515 | 0.040 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 1998 | 102 | 0.040 |
Why?
|
| Angiotensinogen | 1 | 1999 | 161 | 0.040 |
Why?
|
| Cross-Sectional Studies | 10 | 2012 | 26395 | 0.040 |
Why?
|
| Hospital Records | 4 | 1991 | 93 | 0.040 |
Why?
|
| Schizophrenia | 3 | 2011 | 6987 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2001 | 1732 | 0.040 |
Why?
|
| Epidemiologic Research Design | 1 | 2001 | 368 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2202 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2000 | 417 | 0.040 |
Why?
|
| Spirometry | 2 | 2015 | 929 | 0.040 |
Why?
|
| Migraine Disorders | 2 | 2008 | 1713 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2000 | 472 | 0.040 |
Why?
|
| Morbidity | 4 | 1991 | 1757 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3608 | 0.040 |
Why?
|
| Hospitals | 4 | 1991 | 3904 | 0.040 |
Why?
|
| Bronchodilator Agents | 2 | 2015 | 518 | 0.040 |
Why?
|
| Follow-Up Studies | 11 | 2008 | 39394 | 0.030 |
Why?
|
| Brazil | 1 | 2021 | 1250 | 0.030 |
Why?
|
| Hospitals, Urban | 2 | 1997 | 499 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2005 | 2025 | 0.030 |
Why?
|
| Homozygote | 3 | 2011 | 1780 | 0.030 |
Why?
|
| Markov Chains | 1 | 2000 | 979 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 1994 | 5864 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 2004 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1498 | 0.030 |
Why?
|
| Hypertension | 4 | 2001 | 8617 | 0.030 |
Why?
|
| Risk Management | 4 | 1995 | 558 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2006 | 1606 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 1999 | 496 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2001 | 577 | 0.030 |
Why?
|
| Medical Audit | 2 | 2004 | 454 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 1998 | 2862 | 0.030 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2015 | 43 | 0.030 |
Why?
|
| Medical Errors | 1 | 2004 | 1262 | 0.030 |
Why?
|
| Lod Score | 3 | 2004 | 600 | 0.030 |
Why?
|
| Cohort Effect | 1 | 1995 | 39 | 0.030 |
Why?
|
| Penetrance | 1 | 2017 | 386 | 0.030 |
Why?
|
| Air Pollution | 4 | 1997 | 2372 | 0.030 |
Why?
|
| Drug Therapy | 3 | 2010 | 504 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2012 | 65480 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 351 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3780 | 0.030 |
Why?
|
| Tars | 1 | 1994 | 20 | 0.030 |
Why?
|
| Lipids | 1 | 2006 | 3345 | 0.030 |
Why?
|
| Mothers | 2 | 2021 | 2209 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2122 | 0.030 |
Why?
|
| Systems Analysis | 1 | 1995 | 168 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 361 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3278 | 0.030 |
Why?
|
| Child Development | 1 | 1986 | 2336 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1798 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 1987 | 2360 | 0.030 |
Why?
|
| Serpins | 1 | 2015 | 246 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13594 | 0.030 |
Why?
|
| Introns | 2 | 2008 | 969 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2013 | 24333 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2002 | 10765 | 0.030 |
Why?
|
| Photochemotherapy | 2 | 1994 | 830 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2843 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2006 | 2063 | 0.030 |
Why?
|
| Fruit | 1 | 1999 | 1165 | 0.030 |
Why?
|
| Vegetables | 1 | 1999 | 1199 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 1437 | 0.030 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 2013 | 75 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1014 | 0.030 |
Why?
|
| Aging | 3 | 2009 | 8745 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6320 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 56 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2013 | 26 | 0.030 |
Why?
|
| Dietary Fats | 2 | 1999 | 2002 | 0.030 |
Why?
|
| Anti-HIV Agents | 2 | 2000 | 4576 | 0.030 |
Why?
|
| Respiratory Function Tests | 2 | 2002 | 1694 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 7861 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2013 | 99 | 0.030 |
Why?
|
| Intelligence | 1 | 1998 | 927 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1985 | 4045 | 0.030 |
Why?
|
| Physicians | 2 | 2006 | 4607 | 0.030 |
Why?
|
| Psychopathology | 1 | 1995 | 434 | 0.030 |
Why?
|
| Hospitalization | 6 | 2004 | 10847 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 469 | 0.030 |
Why?
|
| Child, Preschool | 9 | 2008 | 42683 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2012 | 54962 | 0.020 |
Why?
|
| Demography | 1 | 2017 | 1642 | 0.020 |
Why?
|
| Incidence | 5 | 2003 | 21547 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5434 | 0.020 |
Why?
|
| Depression | 2 | 2002 | 8231 | 0.020 |
Why?
|
| Physician's Role | 1 | 1998 | 926 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2598 | 0.020 |
Why?
|
| Perphenazine | 1 | 2011 | 33 | 0.020 |
Why?
|
| Time Factors | 6 | 2017 | 40261 | 0.020 |
Why?
|
| Premature Birth | 1 | 2004 | 1830 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 102 | 0.020 |
Why?
|
| Anthropometry | 2 | 2006 | 1345 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 564 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 1995 | 813 | 0.020 |
Why?
|
| Hospital Costs | 1 | 1997 | 959 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2003 | 4413 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1445 | 0.020 |
Why?
|
| Carcinoma, Basal Cell | 2 | 1994 | 565 | 0.020 |
Why?
|
| Binge-Eating Disorder | 1 | 2012 | 156 | 0.020 |
Why?
|
| Urban Health | 1 | 2013 | 535 | 0.020 |
Why?
|
| Liability, Legal | 1 | 1992 | 209 | 0.020 |
Why?
|
| Motivation | 1 | 2000 | 2025 | 0.020 |
Why?
|
| Pregnancy | 6 | 2021 | 30265 | 0.020 |
Why?
|
| Alcohol-Related Disorders | 1 | 2012 | 243 | 0.020 |
Why?
|
| Germany | 1 | 2012 | 883 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11886 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
| Psychometrics | 3 | 2009 | 3066 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 419 | 0.020 |
Why?
|
| Menopause | 2 | 2009 | 1656 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 1066 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
| Health Services Research | 2 | 2004 | 1818 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2011 | 534 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 1998 | 1673 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1994 | 1104 | 0.020 |
Why?
|
| Anxiety | 1 | 2004 | 4672 | 0.020 |
Why?
|
| Aged, 80 and over | 7 | 2011 | 59739 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 246 | 0.020 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 1987 | 46 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2008 | 103 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 385 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6086 | 0.020 |
Why?
|
| Chlorpheniramine | 1 | 1987 | 13 | 0.020 |
Why?
|
| Carboplatin | 1 | 2011 | 799 | 0.020 |
Why?
|
| Methotrexate | 1 | 1994 | 1723 | 0.020 |
Why?
|
| Education, Continuing | 1 | 2008 | 115 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2009 | 221 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 13510 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1999 | 8559 | 0.020 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 1987 | 60 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 1987 | 101 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 2298 | 0.020 |
Why?
|
| China | 2 | 2006 | 2395 | 0.020 |
Why?
|
| Kartagener Syndrome | 1 | 1986 | 33 | 0.020 |
Why?
|
| Lidocaine | 1 | 1989 | 546 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9384 | 0.020 |
Why?
|
| Mathematics | 3 | 1994 | 704 | 0.020 |
Why?
|
| Massachusetts | 1 | 1999 | 8894 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 79 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2006 | 119 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1989 | 775 | 0.020 |
Why?
|
| Dietary Proteins | 3 | 1986 | 960 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1748 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 44 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2812 | 0.020 |
Why?
|
| Perception | 1 | 1992 | 1209 | 0.020 |
Why?
|
| HIV Infections | 2 | 2003 | 17591 | 0.020 |
Why?
|
| Dietary Services | 1 | 1984 | 17 | 0.020 |
Why?
|
| Data Collection | 4 | 2001 | 3324 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1990 | 1159 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2005 | 179 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2013 | 12467 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 137 | 0.010 |
Why?
|
| Reference Values | 2 | 2003 | 4940 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1999 | 4056 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 166 | 0.010 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 122 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2005 | 321 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3070 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
| Laboratories | 1 | 1987 | 463 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1987 | 1034 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2006 | 625 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1994 | 4926 | 0.010 |
Why?
|
| Colonic Diseases, Functional | 1 | 2003 | 39 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1735 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1143 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 350 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2005 | 5801 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1982 | 75 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1983 | 157 | 0.010 |
Why?
|
| Length of Stay | 1 | 1997 | 6526 | 0.010 |
Why?
|
| Infant | 6 | 2008 | 36556 | 0.010 |
Why?
|
| Growth | 1 | 1984 | 366 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20776 | 0.010 |
Why?
|
| Social Change | 1 | 2003 | 152 | 0.010 |
Why?
|
| Nova Scotia | 1 | 2002 | 33 | 0.010 |
Why?
|
| Cataplexy | 1 | 2003 | 62 | 0.010 |
Why?
|
| Antipsychotic Agents | 2 | 2011 | 3081 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1983 | 180 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1983 | 204 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 268 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 272 | 0.010 |
Why?
|
| Cilia | 1 | 1986 | 498 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1983 | 326 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 21188 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1987 | 864 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 2005 | 500 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 515 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.010 |
Why?
|
| Hematocrit | 1 | 1983 | 623 | 0.010 |
Why?
|
| Minerals | 1 | 1983 | 282 | 0.010 |
Why?
|
| Malaria, Falciparum | 1 | 2009 | 1077 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 2252 | 0.010 |
Why?
|
| Affect | 1 | 2009 | 1500 | 0.010 |
Why?
|
| Overweight | 1 | 2012 | 2448 | 0.010 |
Why?
|
| Enkephalins | 1 | 2001 | 139 | 0.010 |
Why?
|
| Social Environment | 1 | 2006 | 1015 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 129 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1991 | 8544 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2003 | 810 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 642 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 2421 | 0.010 |
Why?
|
| Puberty | 1 | 2003 | 501 | 0.010 |
Why?
|
| Infant Behavior | 1 | 2001 | 157 | 0.010 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2006 | 529 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2258 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 2001 | 408 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 12253 | 0.010 |
Why?
|
| DNA | 2 | 2004 | 7214 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 1990 | 2182 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2006 | 1758 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1161 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2003 | 826 | 0.010 |
Why?
|
| Nicotine | 1 | 2004 | 680 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 1483 | 0.010 |
Why?
|
| Europe | 1 | 2006 | 3441 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11932 | 0.010 |
Why?
|
| Family Practice | 1 | 2001 | 509 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1989 | 11521 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 9080 | 0.010 |
Why?
|
| Genomics | 1 | 2014 | 5928 | 0.010 |
Why?
|
| Finland | 1 | 1999 | 609 | 0.010 |
Why?
|
| beta Carotene | 1 | 1999 | 523 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2593 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 15951 | 0.010 |
Why?
|
| Eosinophils | 1 | 2002 | 953 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 3080 | 0.010 |
Why?
|
| Infant, Newborn | 5 | 2006 | 26428 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1997 | 113 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 1256 | 0.010 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 1998 | 197 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2008 | 81903 | 0.010 |
Why?
|
| Platelet Count | 1 | 1999 | 787 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 1135 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2000 | 677 | 0.010 |
Why?
|
| Pharmacies | 1 | 1998 | 171 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4592 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12873 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1255 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2002 | 1506 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3447 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1991 | 4339 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 1960 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11262 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 4423 | 0.010 |
Why?
|
| Animals | 3 | 2001 | 169335 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1541 | 0.010 |
Why?
|
| Vitamin E | 1 | 1999 | 874 | 0.010 |
Why?
|
| Child Behavior | 1 | 2001 | 865 | 0.010 |
Why?
|
| Heart Diseases | 2 | 2001 | 2819 | 0.010 |
Why?
|
| Medical Records | 2 | 1991 | 1411 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1444 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 3621 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6982 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 1998 | 712 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2744 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4356 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1983 | 2059 | 0.010 |
Why?
|
| Anemia | 1 | 1983 | 1517 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 30046 | 0.010 |
Why?
|
| Selection Bias | 1 | 1995 | 360 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2003 | 1811 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1862 | 0.010 |
Why?
|
| Young Adult | 2 | 2009 | 60131 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1983 | 4199 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1983 | 2590 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 2721 | 0.010 |
Why?
|
| Urban Population | 1 | 2000 | 2046 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1979 | 1486 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 2798 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1669 | 0.010 |
Why?
|
| Insurance Claim Reporting | 1 | 1991 | 166 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 7148 | 0.010 |
Why?
|
| Netherlands | 1 | 1995 | 2277 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1999 | 2027 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 1991 | 176 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1991 | 570 | 0.010 |
Why?
|
| Decision Support Systems, Clinical | 1 | 1998 | 1178 | 0.010 |
Why?
|
| Systole | 1 | 1991 | 937 | 0.010 |
Why?
|
| Diastole | 1 | 1991 | 785 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12806 | 0.000 |
Why?
|
| Coronary Disease | 2 | 1983 | 5919 | 0.000 |
Why?
|
| Wound Infection | 1 | 1991 | 243 | 0.000 |
Why?
|
| Pharmaceutical Preparations | 1 | 1997 | 1088 | 0.000 |
Why?
|
| Astemizole | 1 | 1987 | 2 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1999 | 2913 | 0.000 |
Why?
|
| Peer Review | 1 | 1989 | 219 | 0.000 |
Why?
|
| Mutagens | 1 | 1987 | 181 | 0.000 |
Why?
|
| Dextrocardia | 1 | 1986 | 37 | 0.000 |
Why?
|
| Dyneins | 1 | 1986 | 126 | 0.000 |
Why?
|
| Long-Term Care | 1 | 1989 | 631 | 0.000 |
Why?
|
| Insurance Claim Review | 1 | 1990 | 746 | 0.000 |
Why?
|
| California | 1 | 1989 | 1443 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1987 | 347 | 0.000 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2003 | 4640 | 0.000 |
Why?
|
| Quality Control | 1 | 1987 | 836 | 0.000 |
Why?
|
| Minority Groups | 1 | 1991 | 1216 | 0.000 |
Why?
|
| Disability Evaluation | 1 | 1991 | 1839 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 1281 | 0.000 |
Why?
|
| Skinfold Thickness | 1 | 1983 | 164 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5892 | 0.000 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1983 | 124 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1995 | 3800 | 0.000 |
Why?
|
| Nutritional Requirements | 1 | 1983 | 279 | 0.000 |
Why?
|
| Mental Health | 1 | 1995 | 3275 | 0.000 |
Why?
|
| Disabled Persons | 1 | 1991 | 1210 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1991 | 2649 | 0.000 |
Why?
|
| Phosphates | 1 | 1983 | 765 | 0.000 |
Why?
|
| Maternal Health Services | 1 | 1984 | 472 | 0.000 |
Why?
|
| Potassium | 1 | 1983 | 1315 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2488 | 0.000 |
Why?
|
| Health Status | 1 | 1991 | 4095 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1990 | 2517 | 0.000 |
Why?
|
| Sinusitis | 1 | 1986 | 998 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1983 | 1803 | 0.000 |
Why?
|
| Eating | 1 | 1983 | 1542 | 0.000 |
Why?
|
| Creatinine | 1 | 1981 | 1917 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1991 | 4860 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13698 | 0.000 |
Why?
|
| Heart Failure | 1 | 1979 | 11879 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1990 | 14752 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1983 | 1204 | 0.000 |
Why?
|
| Calcinosis | 1 | 1983 | 1479 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 82072 | 0.000 |
Why?
|
| Mortality | 1 | 1981 | 2914 | 0.000 |
Why?
|
| Calcium | 1 | 1983 | 5792 | 0.000 |
Why?
|
| Vitamin D | 1 | 1983 | 3311 | 0.000 |
Why?
|
| Neoplasms | 1 | 1998 | 22389 | 0.000 |
Why?
|
| Diet | 1 | 1983 | 8088 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1983 | 15661 | 0.000 |
Why?
|